Genetic characterization and genotyping of hepatitis B virus (HBV) isolates from donors with an occult HBV infection

Vox Sanguinis

Volumn 107, Issue 4, 2014, Pages 324-332

  Chamni, N ^a   Louisirirotchanakul, S ^a   Oota, S ^b   Sakuldamrongpanish, T ^b   Saldanha, J ^c   Chongkolwatana, V ^a   Phikulsod, S ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c Immucor Inc   (United States)

Author keywords

Genotype I; Hepatitis B virus; Mutation; Occult; Sequencing

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

BLOOD; BLOOD DONOR; CLASSIFICATION; EYE DISEASE; GENETICS; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYLOGENY; POLYMERASE CHAIN REACTION; PROMOTER REGION; VIROLOGY;

BASE SEQUENCE; BLOOD DONORS; DNA, VIRAL; EYE DISEASES; GENOTYPE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC;

EID: 84911905167     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12178     Document Type: Article

References (38)

1. Merican I, Guan R, Amarapuka D, et al.: Chronic hepatitis B virus in Asian countries. J Gastroenterol Hepatol 2000; 15:1356-1361
2. Liu CJ, Chen DS, Chen PJ: Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006; 36:S33-S44
3. Allain J-P: Occult hepatitis B infection: implications in transfusion. Vox Sang 2004; 86:83-91
4. Raimondo G, Pollicino T, Cacciola I, et al.: Occult hepatitis B infection. J Hepatol 2007; 46:160-170
5. Brojer E, Grabarczyk P, Liszewski G, et al.: Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology 2006; 44:1666-1674
6. Zahn A, Li C, Danso K, et al.: Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol 2008; 89:409-418
7. Van Hemert FJ, Zaaijer HL, Berkhout B, et al.: Occult hepatitis B infection: an evolutionary scenario. Virol J 2008; 5:146
8. Katsoulidou A, Paraskevis D, Magiorkinis E, et al.: Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol 2009; 81:815-825
9. González R, Torres P, Castro E, et al.: Efficacy of hepatitis B virus (HBV) screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion 2010; 50:221-230
10. Arababadi MK, Ahmadabadi BN, Kennedy D: Current information on the immunological status of occult hepatitis B infection. Transfusion 2012; 52:1819-1826
11. Phikulsod S, Oota S, Tirawatnapong T, et al.; Working Group for NAT Study in Thai Blood Donations: One year experience of nucleic acid technology testing for human immunodeficiency virus type 1, hepatitis C virus and hepatitis B virus in Thai blood donations. Transfusion 2009; 49:1126-1135
12. Louisirirotchanakul S, Oota S, Khuponsarb K, et al.; Working Group for NAT Study in Thai Blood Donations: Occult HBV infection in Thai blood donors. Transfusion 2011; 51:1532-1540
13. Candotti D, Lin CK, Belkhiri D, et al.: Occult hepatitis B infection in blood donors from South East Asia: molecular characterization and potential mechanisms of occurrence. Gut 2012; 61:1744-1753
14. ® TaqScreen MPX Test for Use on the cobas s 201 System, Rev. 5, 01/2010. Package Insert, Branchburg, NJ, USA, Roche Molecular Systems, Inc
15. Procleix Ultrio Assay. For In Vitro Diagnostic Use. Rev. A, Package Insert, Gen-Probe U.S., 2008
16. Hussain M, Chu CJ, Sablon E, et al.: Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants. J Clin Microbiol 2003; 41:3699-3705
17. Lindh M, Andersson AS, Gusdal A: Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect 1997; 175:1285-1293
18. Lindh M, Gonzalez JE, Norkrans G, et al.: Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods 1998; 72:163-174
19. Alestig E, Hannoun C, Horal P, et al.: Hepatitis B virus genotypes in Mongols and Australian aborigines. Arch Virol 2001; 146:2321-2329
20. Sugauchi F, Orito E, Kato H, et al.: Genotype, serotype, and phylogenetic characterization of the complete genome sequence of hepatitis B virus isolates from Malawian chronic carriers of the virus. J Med Virol 2003; 69:33-40
21. Tran TT, Trinh TN, Abe K: New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 2008; 82:5657-5663
22. Olinger CM, Jutavijittum P, Hübschen JM, et al.: Possible new hepatitis B virus genotype, Southeast Asia. Emerg Infect Dis 2008; 14:1777-1780
23. Premashish K: Hepatitis B virus genotyping: will it stand the test of time? Gastroenterol 2005; 24:4-5
24. Louisirirotchanakul S, Olinger CM, Arunkaewchaemsri P, et al.: The distribution of hepatitis B virus genotypes in Thailand. J Med Virol 2012; 84:1541-1547
25. Candotti D, Grabarczyk P, Ghiazza P, et al.: Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. Hepatology 2008; 49:537-547
26. Jongerius JM, Wester M, Cuypers HT, et al.: New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 1998; 38:56-59
27. Chong-Jin O, Wei Ning C, Shiuan K, et al.: Identification of hepatitis bsurface antigen variants with alterations outside the 'a' determinant in immunized Singapore infants. J Infect Dis 1999; 179:259-263
28. Louisirirotchanakul S, Kanoksinsombat C, Theamboonlert A, et al.: Mutation of the 'a' determinant of HBsAg with discordant HBsAg diagnostic kits. Viral Immunol 2004; 17:440-444
29. Moerman B, Moons V, Sommer H, et al.: Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab 2004; 50:159-162
30. ® Centaur HBsAg screening assays. J Med Virol 2010; 82:755-762
31. Osiowy C: Detection of HBsAg mutants. J Med Virol 2006; 78(Suppl. 1):S48-S51
32. Vivekanandan P, Kannangai R, Ray SC, et al.: Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis 2008; 46:1227-1236
33. Allain JP, Belkhiri D, Vermeulen M, et al.: Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 2009; 49:1868-1876
34. Okamoto H, Tsuda F, Akahane Y, et al.: Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994; 1994:8102-8110
35. Takahashi K, Aoyama K, Ohno N, et al.: The precore/core promoter mutant (T1762A 1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol 1995; 76:3159-3164
36. Brunetto MR, Stemler M, Schodel F, et al.: Identification of HBV variants which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol 1989; 21:151-154
37. Carman WF, Jacyna MR, Hadziyannis S, et al.: Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection 1989. Lancet 1989; 2:588-591
38. Okamoto H, Yotsumoto S, Akahane Y, et al.: Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990; 64:1298-1303